Cargando…

Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review

SIMPLE SUMMARY: Bladder cancer (BC) is one of the most frequent cancers in the world and the urological tumor that presents the highest mortality. The diagnostic and prognostic methods available at present for BC are expensive and highly invasive for the patient, so the pursue of biomarkers that may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herranz, Raquel, Oto, Julia, Plana, Emma, Fernández-Pardo, Álvaro, Cana, Fernando, Martínez-Sarmiento, Manuel, Vera-Donoso, César D., España, Francisco, Medina, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005001/ https://www.ncbi.nlm.nih.gov/pubmed/33810039 http://dx.doi.org/10.3390/cancers13061448

Ejemplares similares

Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer
por: Oto, Julia, et al.
Publicado: (2020)

Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro
por: Herranz, Raquel, et al.
Publicado: (2023)

Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs
por: Oto, Julia, et al.
Publicado: (2021)

Increase of Neutrophil Activation Markers in Venous Thrombosis—Contribution of Circulating Activated Protein C
por: Martos, Laura, et al.
Publicado: (2020)

microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors
por: Oto, Julia, et al.
Publicado: (2020)

A predictive model for prostate cancer incorporating PSA molecular forms and age
por: Oto, Julia, et al.
Publicado: (2020)

MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma
por: Oto, Julia, et al.
Publicado: (2020)

Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review
por: Găman, Mihnea-Alexandru, et al.
Publicado: (2021)

Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation
por: Ramón-Núñez, Luis A., et al.
Publicado: (2017)

Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2018)

Cell-free DNA liquid biopsy for early detection of gastrointestinal cancers: A systematic review
por: Uhe, Isabelle, et al.
Publicado: (2021)

Liquid biopsies for bladder cancer
por: Ward, Douglas G., et al.
Publicado: (2017)

Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review
por: Anderson, D. J., et al.
Publicado: (2020)

Liquid Biopsy in Diagnosis and Prognosis of High-Grade Gliomas; State-of-the-Art and Literature Review
por: Bonosi, Lapo, et al.
Publicado: (2022)

The Clinical Applications of Liquid Biopsies in Pediatric Brain Tumors: A Systematic Literature Review
por: Greuter, Ladina, et al.
Publicado: (2022)

Cancer Biomarkers in Liquid Biopsy for Early Detection of Breast Cancer: A Systematic Review
por: Duque, Galo, et al.
Publicado: (2022)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
por: Toledano-Fonseca, Marta, et al.
Publicado: (2020)

Laser transfer for circulating tumor cell isolation in liquid biopsy
por: Molpeceres, Carlos, et al.
Publicado: (2023)

Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013)

Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review
por: Fagery, Mussab, et al.
Publicado: (2023)

Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
por: Heidrich, Isabel, et al.
Publicado: (2022)

Bioengineering Approaches for Bladder Regeneration
por: Serrano-Aroca, Ángel, et al.
Publicado: (2018)

Circulating platelets as liquid biopsy sources for cancer detection
por: Antunes‐Ferreira, Mafalda, et al.
Publicado: (2020)

Emerging role of liquid biopsy of cell-free tumor DNA for bladder cancer surveillance
por: Kang, Minyong, et al.
Publicado: (2017)

Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis
por: Pizzutilo, Elio Gregory, et al.
Publicado: (2021)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
por: Hocking, Jay, et al.
Publicado: (2016)

Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
por: Huang, Hai‐Ming, et al.
Publicado: (2020)

Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
por: Sato, Akemi, et al.
Publicado: (2018)

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol
por: Sorber, Laure, et al.
Publicado: (2019)

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma
por: Lyu, Xueying, et al.
Publicado: (2022)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

Recent Advances in Liquid Biopsy Based on Circulating Tumor DNA
por: Sakuma, Yu, et al.
Publicado: (2019)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022)

Analysis of colorectal cancer‐related mutations by liquid biopsy: Utility of circulating cell‐free DNA and circulating tumor cells
por: Takeda, Kohki, et al.
Publicado: (2019)

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
por: Okajima, Wataru, et al.
Publicado: (2017)

Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
por: Yuan, Zuyang, et al.
Publicado: (2020)

Circulating Cell-Free DNA in Inflammatory Bowel Disease: Liquid Biopsies with Mechanistic and Translational Implications
por: Chuah, Cher Shiong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_onjdk131p127h2a6hl1jlak66j